1st Global AYA Cancer Congress, Edinburgh, 5-7 Dec 2016
Save the date and register your interest!
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Save the date and register your interest!
Indicated for patients with newly-diagnosed glioblastoma multiforme
It is intended for the reduction of hypercalcaemia in patients with parathyroid carcinoma
Researchers report that the original cancer in a patient’s body may have important differences at a genetic level from cancer that has spread to the patient’s brain
An international team of researchers has shown that the use of the mTOR inhibitor everolimus can delay tumour growth among both gastrointestinal and lung NETs
Long-term follow-up of EORTC study strongly supports adding regional hyperthermia to neoadjuvant chemotherapy
The SIOPE Session, Tackling Rare Cancers Requiring Specialist Care: ERNs, & Scientific Symposium: Bayesian, Adaptive and Rare Disease Designs
Scientists identify a new drug target and demonstrate its effectiveness compared to existing treatments
Providing an update on key diagnostic, clinical, molecular, prognostic and predictive characteristics in patients with newly diagnosed and recurrent glioblastomarovide an update on key diagnostic, clinical, molecular, prognostic and predictive characteristics in patients with newly diagnosed and recurrent glioblastoma
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.